Mitchell Tatjana 4

What Happened

• Mitchell Tatjana, Chief Financial Officer of Evolus (EOLS), received equity awards on February 17, 2026 comprising 121,489 restricted stock units (RSUs), 121,489 performance-based restricted stock units (PSUs), and 177,471 option-related shares (derivative award). All grants were recorded at $0.00 (awards granted, not purchased) for a total of 420,449 shares (aggregate potential shares issuable).

Key Details

• Transaction date: February 17, 2026; Form 4 filed February 19, 2026 (timely filing).
• Reported price: $0.00 for each award (standard grant/award reporting; no cash paid by the insider).
• Total potential shares: 420,449 (121,489 RSUs + 121,489 PSUs + 177,471 option-related).
• Vesting and payout notes:
  • RSUs (F1): Each RSU converts to one share and vests in four equal annual installments beginning Feb 17, 2026, subject to continued service and certain acceleration events.
  • PSUs (F2–F3): Each PSU can convert into up to 200% of the PSU count depending on performance versus financial and relative TSR metrics over a three-year performance period ending Dec 31, 2028; any earned PSUs vest after certification of results.
  • Option-related award (F4): Shares subject to the option vest in four equal annual installments beginning Feb 17, 2026, subject to continued service and possible acceleration.
• Shares owned after the transaction: not specified in the provided filing details.
• No tax-withholding or 10b5-1 plan noted in the supplied information.

Context

• These entries are grant-type awards (transaction code A). The PSUs and option-related entries are derivative awards — they do not represent immediate sales or purchases of stock but potential future issuance if vesting/performance requirements are met.
• Because these awards were granted (not bought or sold), they are compensation-related and should be viewed as part of executive pay rather than a direct market sentiment signal.